Inventor
Shlomo Melmed
Inventor
Los Angeles, CA, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
C07KPeptides20%
A01KAnimal husbandry19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11%
C12NMicroorganisms or enzymes10%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
C12YEnzymes1%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
9,387,211'Methods for treatment of Cushing\'S disease and hypercortisolism using gefitinib'20168,709,804'Method for drug screening and characterization by calcium flux'20148,216,782'PTTG1 as a biomarker for cancer treatment'20127,097,829'Transgenic cells transfected with pituitary tumor transforming gene (PTTG)) expression vectors and uses therefor'20066,943,018'Transgenic expression from a SOCS-3 promoter in vertebrate cells'20056,939,544'Antibodies against mouse pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides'20056,913,926'Method of regulating biological activity of pituitary tumor transforming gene (PTTG)1 using PTTG2'20056,911,320'Rat PTTG polypeptide and method for producing it'20056,909,030'PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes'20056,900,032'Human PTTG polypeptide and method for producing it'20056,894,031'Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation'20056,858,586'Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation'20056,835,380'Antibodies against rat pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides'20046,750,327'Compositions and method for determining the presence of human PTTG peptide in a sample'20046,723,519'Compositions and method for determining the presence of rat PTTG peptide in a sample'20046,673,823'Use of peroxisome proliferator activated receptor (PPAR)- ligands as a treatment for pituitary tumors and associated conditions, such as Cushing\'s syndrome'20046,541,244'Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans'20036,455,305'Pituitary-tumor-transforming-genes, and related products'20025,972,893'Method of treating hyperprolactinemia and prolactinomas'19995,942,412'Polynucleic acid encoding variant insulin-like growth factor I receptor beta subunit and receptor'19995,824,838'Transgenic mouse model for pituitary disorders associated with LIF overexpression and/or GH underexpression, and its use for testing therapeutic drugs for the conditions'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2016Patents assigned to CEDARS SINAI MEDICAL CENTER (21)· patent assignee history
1998–2016Based in Los Angeles, CA, US· patent location history
1999Patents assigned to BIOMEASURE INC (1)· patent assignee history
2012–2016Patents assigned to MELMED SHLOMO (3)· patent assignee history
2014Patents assigned to BEN-SHLOMO ANAT (1)· patent assignee history
2016Patents assigned to FUKUOKA HIDENORI (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CEDARS SINAI MEDICAL CENTER | 21 | 1998–2016 |
| MELMED SHLOMOself | 3 | 2012–2016 |
| BEN-SHLOMO ANAT | 1 | 2014 |
| BIOMEASURE INC | 1 | 1999 |
| FUKUOKA HIDENORI | 1 | 2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Los Angeles, California, US | 21 | 1998–2016 |